AURA Takes you to the home page
 

Aberdeen University Research Archive >

Browsing by Subject Parkinson's disease

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
Jul-2016In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizinSantoro, Matteo; Maetzler, Walter; Stathakos, Petros; Martin, Heather L; Hobert, Markus A; Rattray, Tim W; Gasser, Thomas; Forrester, John V; Berg, Daniela; Tracey, Kevin J; Riedel, Gernot; Teismann, Peter; University of Aberdeen, School of Medical Sciences; University of Aberdeen, University of Aberdeen; University of Aberdeen, Medicine, Medical Sciences & Nutrition, Applied Medicine; University of Aberdeen, Medicine, Medical Sciences & Nutrition, Medical Sciences
Nov-2015Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseMounsey, Ross B; Mustafa, Sarah; Robinson, Lianne; Ross, Ruth A.; Riedel, Gernot; Pertwee, Roger G.; Teismann, Peter; University of Aberdeen, Medicine, Medical Sciences & Nutrition, Medical Sciences
30-Nov-2013The Mini-Mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's diseaseCaslake, Robert; Summers, Fiona; McConachie, Douglas; Ferris, Catriona; Gordon, Joanna; Harris, Clare; Caie, Linda; Counsell, Carl; University of Aberdeen, School of Medicine & Dentistry, Division of Applied Health Sciences; University of Aberdeen, University of Aberdeen; University of Aberdeen, School of Psychology; University of Aberdeen, Chronic Disease Research Group; University of Aberdeen, Data Safe Haven
Nov-2014Mortality in Parkinson's disease : A systematic review and meta-analysisMacLeod, Angus D; Taylor, Kate S M; Counsell, Carl E; University of Aberdeen, Medicine, Medical Sciences & Nutrition, Institute of Applied Health Sciences; University of Aberdeen, Medicine, Medical Sciences & Nutrition, Other Applied Health Sciences; University of Aberdeen, REF 2014 UoA 2 Public Health, Health Services and Primary Care; University of Aberdeen, Chronic Disease Research Group; University of Aberdeen, Data Safe Haven
Oct-2012Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicityTeismann, Peter; Sathe, Kinnari; Bierhaus, Angelika; Leng, Lin; Martin, Heather L; Bucala, Richard; Weigle, Bernd; Nawroth, Peter P.; Schulz, Jörg B.; University of Aberdeen, School of Medical Sciences
Nov-2012S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathwaySathe, Kinnari; Maetzler, Walter; Lang, Johannes; Mounsey, Ross Brian; Fleckenstein, Corinna; Martin, Heather Louise; Schulte, Claudia; Mustafa, Sarah; Synofzik, Matthis; Vukovic, Zvonimir; Itohara, Shigeyoshi; Berg, Daniela; Teismann, Peter; University of Aberdeen, Medicine, Medical Sciences & Nutrition, Institute of Medical Sciences
Aug-2010Timed tests of motor function in Parkinson's diseaseMacLeod, Angus D; Counsell, Carl E; University of Aberdeen, School of Medicine & Dentistry, Other Applied Health Sciences; University of Aberdeen, School of Medicine & Dentistry, Division of Applied Health Sciences; University of Aberdeen, Data Safe Haven
Showing results 1 to 7 of 7

 


The University of Aberdeen
King's College
Aberdeen
AB24 3FX
Tel: +44 (0)1224-272000